Cargando…

Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa

Detalles Bibliográficos
Autores principales: Vicens‐Artés, Sònia, Roca‐Ferrer, Jordi, Tubita, Valeria, Fuentes, Mireya, Alobid, Isam, Valero, Antonio, Kopietz, Ferdinand, Nguyen, DucTung, Mullol, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305966/
https://www.ncbi.nlm.nih.gov/pubmed/35066955
http://dx.doi.org/10.1111/cea.14099
_version_ 1784752445382983680
author Vicens‐Artés, Sònia
Roca‐Ferrer, Jordi
Tubita, Valeria
Fuentes, Mireya
Alobid, Isam
Valero, Antonio
Kopietz, Ferdinand
Nguyen, DucTung
Mullol, Joaquim
author_facet Vicens‐Artés, Sònia
Roca‐Ferrer, Jordi
Tubita, Valeria
Fuentes, Mireya
Alobid, Isam
Valero, Antonio
Kopietz, Ferdinand
Nguyen, DucTung
Mullol, Joaquim
author_sort Vicens‐Artés, Sònia
collection PubMed
description
format Online
Article
Text
id pubmed-9305966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93059662022-07-28 Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa Vicens‐Artés, Sònia Roca‐Ferrer, Jordi Tubita, Valeria Fuentes, Mireya Alobid, Isam Valero, Antonio Kopietz, Ferdinand Nguyen, DucTung Mullol, Joaquim Clin Exp Allergy Research Letters John Wiley and Sons Inc. 2022-02-04 2022-06 /pmc/articles/PMC9305966/ /pubmed/35066955 http://dx.doi.org/10.1111/cea.14099 Text en © 2022 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Letters
Vicens‐Artés, Sònia
Roca‐Ferrer, Jordi
Tubita, Valeria
Fuentes, Mireya
Alobid, Isam
Valero, Antonio
Kopietz, Ferdinand
Nguyen, DucTung
Mullol, Joaquim
Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
title Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
title_full Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
title_fullStr Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
title_full_unstemmed Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
title_short Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
title_sort superior effect of mp‐azeflu compared to monotherapy with fluticasone propionate or azelastine on gilz, mkp‐1 and ttp anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305966/
https://www.ncbi.nlm.nih.gov/pubmed/35066955
http://dx.doi.org/10.1111/cea.14099
work_keys_str_mv AT vicensartessonia superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT rocaferrerjordi superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT tubitavaleria superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT fuentesmireya superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT alobidisam superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT valeroantonio superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT kopietzferdinand superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT nguyenductung superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa
AT mulloljoaquim superioreffectofmpazeflucomparedtomonotherapywithfluticasonepropionateorazelastineongilzmkp1andttpantiinflammatorygeneexpressioninhealthyandinflamedupperairwaymucosa